Globally, disability due to #Parkinsons is increasing faster than for any other neurological disorder 🧠 Carlo Alberto Artusi (Università di Torino) comments on quality of life in patients with Parkinson’s disease: ow.ly/oWHE50NAOyz #WorldParkinsonsDay #TheSpark Parkinson's UK MDS

Should we offer deep brain stimulation to Parkinson’s disease patients with GBA mutations? #ParkinsonsDisease #dbs #Genetics frontiersin.org/articles/10.33…

New congress of the Italian #Parkinson Society, new #young group, same enthusiasm. Passion, work and fun. Accademia LIMPE-DISMOV

"Accuracy in defining endophenotypes of “typical #Parkinsons” across different but interrelated disciplines will enable better definition of variants & their stratification in therapeutic trials, a prerequisite for breakthroughs in precision medicine" …mentdisorders.onlinelibrary.wiley.com/doi/10.1002/md…

Can GPT-4 solve really hard medical cases and come up with a good list of differential diagnoses? @zahirkanjee Byron Crowe and my study is out in JAMA , and the short answer is, “Yes.” But what does this all mean? 🧵⬇️ x.com/JAMA_current/s…

One week of cerebellar transcranial direct current stimulation (ctDCS) in a randomized single-blind, sham-controlled crossover trial of Friedreich's Ataxia (n=24) led to improved SARA scores and fMRI findings confirming target engagement. loom.ly/LXBXBfQ

Very interesting study! A new biomarker for PD severity?

From a #parkin #early-onset #parkinson cohort, an outline on #pregnancy and clinical changes due to fertile life. #gendermedicine #young-onset #yopd #eopd ⁦Carlo Alberto Artusi⁩ link.springer.com/article/10.100…

BoNT can be of help in maintaining posture stability over time. Most patients opted to continue BoNT treatment >12 months. doi: 10.3390/toxins15090566. MDPI

Saw another patient with sensory neuronopathy who had been misdiagnosed with functional neurological disorder. What is sensory neuronopathy, and why do we keep missing it? A #tweetorial. 1/

PRD Editor Dr. Hubert Fernandez pays tribute to the 45 individuals in the PRD 100 Club: prd-journal.com/article/S1353-…. A heartfelt thanks to these 45 experts who have reviewed more than 100 or more papers for Parkinsonism and Related Disorders! #PRDjournal

The final part of the post is the most important! Very well-said and wise comment on the differences about what we (little) know 'at a group' level and what we can learn by single cases and long-term experience. Still, it is important keep pushing the research on surgicogenomics

Big news with positive result announced for a randomized study of a GLP-1 agonist for Parkinson's just released NEJM. A new era for Parkinson's or alternatively, more questions than answers raised by Meissner and colleagues. Key Points: - This multi-center French trial studied

People with 2 copies of APOE4 were known to have a high risk of #Alzheimers. Today that changed to nearly 100% full penetrance NATURE.med nature.com/articles/s4159…

Meeting legends at FNDS Congress in Verona

Today, another awesome Moviews webinar. Prof. Isaias and Jorik Nonnekes will talk about freezing of gait! Not to miss! itlavmeeting.it/Home/Iscrizion…

Neurological conditions now leading cause of ill health and disability globally, affecting 3.4 billion people worldwide, suggests GBD study in The Lancet Neurology On #WorldBrainDay: ➡️ Read the paper: hubs.li/Q02GWZ5F0 ➡️ Explore the infographic: hubs.li/Q02GWMJ00

A Summary of the MDS ‘Statement of the MDS on Biological Definition, Staging and Classification of Parkinson’s Disease’ movementdisorders.org/Moving-Along/2… Agreed!

Excited to share our latest publication in Lancet Neurology: "Advances in diagnosis, classification, and management of pain in Parkinson’s disease". Grateful for this great collaboration! 🙌 🔗 sciencedirect.com/science/articl… #Parkinsons #PainManagement